Does the extent of lymph nodes dissection affect the prognosis of resected stage IA non-small cell lung cancer?

about

Does the extent of lymph nodes dissection affect the prognosis of resected stage IA non-small cell lung cancer?

Item

http://www.wikidata.org/entity/Q46154890

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Does the extent of lymph nodes ...... IA non-small cell lung cancer?

@en

Does the extent of lymph nodes ...... IA non-small cell lung cancer?

@nl

type

Item

label

Does the extent of lymph nodes ...... IA non-small cell lung cancer?

@en

Does the extent of lymph nodes ...... IA non-small cell lung cancer?

@nl

prefLabel

Does the extent of lymph nodes ...... IA non-small cell lung cancer?

@en

Does the extent of lymph nodes ...... IA non-small cell lung cancer?

@nl

P1476

Does the extent of lymph nodes ...... IA non-small cell lung cancer?

@en

P2093

C Wang

http://www.w3.org/2001/XMLSchema#string

F Xu

http://www.w3.org/2001/XMLSchema#string

L Qi

http://www.w3.org/2001/XMLSchema#string

Q Li

http://www.w3.org/2001/XMLSchema#string

W Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Revisions in the International System for Staging Lung Cancer

Cancer statistics, 2009

Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 T

Patients with stage I non-small cell lung carcinoma at postoperative risk for local recurrence, distant metastasis, and death: implications related to the design of clinical trials.

The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer.

Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer.

Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.

Incidence of occult mediastinal node involvement in cN0 non-small-cell lung cancer patients after negative uptake of positron emission tomography/computer tomography scan.

Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Eastern Cooperative Oncology Group.

Refractory remodeling of the microenvironment by abnormal type V collagen, apoptosis, and immune response in non-small cell lung cancer.

P2888

s12094-013-1043-z

P304

77-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12094-013-1043-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23615980

http://www.w3.org/2001/XMLSchema#string